Timely meta-analysis on the efficacy of adoptive immunotherapy for hepatocellular carcinoma patients after curative therapy.

Han-Yue MoYing-Yang LiaoXue-Mei YouAlessandro CucchettiBao-Hong YuanRu-Hong LiJian-Hong ZhongLe-Qun Li

Published in: PloS one (2017)

This timely meta-analysis confirms the evidence that adjuvant AIT for patients with HCC after curative treatment lowers risk of mortality and tumor recurrence.

Keyphrases

systematic review
prognostic factors
meta analyses
end stage renal disease
newly diagnosed
ejection fraction
early stage
rectal cancer
cell therapy
randomized controlled trial
case control
type diabetes
stem cells
coronary artery disease
replacement therapy